ISPOR 2024 News Center

Explore the news and reporting from ISPOR 2024 in the News Center with curated stories on cutting-edge topics from the conference. Stories are added to the News Center as they are published, so check back often for conference news.

ISPOR 2024 Daily Round-Ups: Day 3

2024/05/09 | The Evidence Base

ISPOR 2024 Daily Round-Ups: Day 2

2024/05/07 | The Evidence Base

ISPOR 2024 Daily Round-Ups: Day 1

2024/05/06 | The Evidence Base

ISPOR 2024: A Transformative Force for Whole Health

The ISPOR 2024 international conference, HEOR: A Transformative Force for Whole Health, is a must-attend event that convenes global thought leaders to  discuss how the field of health economics and outcomes research (HEOR) can contribute toward whole health.

Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More [AJMC]

The Luxury of Health “Care”: Reflections from ISPOR 2024 [The Evidence Base]

ISPOR 2024: Global Consequences of the IRA in the U.S. & the JCA in Europe [Navlin Daily]

ISPOR 2024: RWE-Driven Payment Approaches for Cell & Gene Therapies [Navlin Daily]

Navigating Uncertainty: Redefining Healthcare Value in an Evolving Healthcare Landscape [The Evidence Base]

Understanding Payer Perceptions of Health Inequalities in Health Technology Assessment and Reimbursement Decision Making [The Evidence Base]

[Podcast] Using Large Language Models to Extract PD-L1 Testing Details from Electronic Health Records [The Evidence Base]

Moderna Will Have to Wait for FDA Approval of Investigational RSV Vaccine [Patient Care]

ISPOR 2024: Health Economists Want to Maximize QALYs, but do Patients? [Navlin Daily]

Key Themes from ISPOR 2024 [Blue Matter Consulting]

ISPOR 2024: A Global Perspective on Incorporating Health Equity in HTA [Navlin Daily]

[Video] Dr Phaedra Corso Discusses How to Incorporate Economic Research Into Health Policy [AJMC]

How to Integrate Factors Relevant to CMS Drug Price Negotiations [Navlin Daily]

ISPOR 2024 – Inside the Third Plenary: Leveraging AI in HEOR and HTA to Enable Whole Health [The Evidence Base]

ISPOR 2024 Daily Round-Ups: Day 3 [The Evidence Base]

ISPOR Panel Explains CMS Pathway to Cover New Technology [AJMC]

[Video] Dr William Padula Explores Applications of Cost-Effectiveness Analysis in Health Care [AJMC]

ISPOR 2024: Exploring Alternatives to the QALY for Research and Policymaking [Navlin Daily]

Posters Detail Effects—and Uncertainty—of Drug Pricing Negotiations [AJMC]

ISPOR 2024: The Motives Behind CMS Price Negotiation [Navlin Daily]

ISPOR 2024 – Inside the Second Plenary: Integration and Linkage of RWD in HEOR [The Evidence Base]

ISPOR 2024 Daily Round-Ups: Day 2 [The Evidence Base]

[Video] Dr Nancy Dreyer Highlights the Advantages of a Direct-to-Patient Approach in Observational Research [AJMC]

ISPOR 2024 Daily Round-Ups: Day 1 [The Evidence Base]

ISPOR 2024 – Inside the First Plenary: Are We Succeeding in HEOR to Advance Whole Health? [The Evidence Base]

Addressing Whole Health Takes Rethinking Partnerships, Metrics, and Delivery [AJMC]

ISPOR Panelists: Can the FDA Advisory Committee Process Be Strengthened? [AJMC]

Impact of IRA Seen as ISPOR 2024 Heads to Atlanta [AJMC]

Getting the Math Right: The Growing Movement to Improve How Medicines Are Valued Will Take Center Stage at ISPOR 2024 [Yahoo! Finance]

[Video] Dr Darius Lakdawalla Previews the ISPOR 2024 Conference [AJMC]

Countdown to ISPOR 2024 [The Evidence Base]

Insights into ISPOR 2024: An Interview with Rob Abbott, ISPOR [The Evidence Base]

The Role of Economic Evaluation in US Healthcare [PMLive]

ISPOR 2024: Navigating the Conference Program [The Evidence Base]

ISPOR 2024: Preview of the Plenary Sessions [The Evidence Base]

ISPOR Patient-Centered Research Summit 2024: Event Preview [The Evidence Base]

ISPOR 2024 Plenaries and Speakers Announced [ISPOR]

ISPOR Announces Patient-Centered Research Summit 2024 [ISPOR]

ISPOR 2024: First Look at the Conference Program [The Evidence Base]


Photo Gallery

ISPOR 2024 Plenary 3 Panel

ISPOR 2024 P2 Ebere

ISPOR 2024 P1 Brian O'Rourke

ISPOR 2024 Posters

ISPOR 2024 Logo Sculpture

ISPOR 2024 - Take a Deep Dive

ISPOR 2024 - Mike Drummond

ISPOR 2024 P! Plenary in Progress

ISPOR 2024 Exhibit Floor 2024-05-06

ISPOR 2024 Sunday Audeince

ISPOR 2024 P3 Rob Abbott

ISPOR 2024 P2 Panel

ISPOR 2024 P1 Plenary Post-Event

ISPOR 2024 Booth Selfie 2024-05-06

ISPOR 2024 Patient Summit

Additional News From the Conference

Hot Takes from ‘Hotlanta’ – ISPOR 2024 [Panalgo]

Making Clinical Advances Accessible to Every Patient: Download 28 Research Posters Presented by Avalere Health at ISPOR 2024 [Avalere Health]

ISPOR 2024 Is "In the Books" [Costello Medical]

Unveiling The Key Trends and Topics: Axtria's Insights from ISPOR US 2024 [Axtria]

BioCryst Presents New Real-World Evidence Showing Significant Reductions in Healthcare Resource Utilization Among Patients with HAE Following Initiation of ORLADEYO® (berotralstat) [Global News Wire]

Global Heart Hub's Real-Life Data Highlights Need for Patient-Centered Management of Unhealthy Cholesterol [PR NewsWire]

Evidation Shares Real-World Data on GLP-1 Use and Social Determinants of Health at ISPOR 2024 [Yahoo! Finance]

First-Ever Cost-Effectiveness Analysis of a Factor XI Inhibitor Demonstrates that Abelacimab, if Approved, Could Offer Significant Cost Savings as Compared to a Current Standard of Care Anticoagulant [Morningstar]

Amplity Health Study Identifies Clinical and Humanistic Burden of Alzheimer's Disease in the United States [Cison]

DistillerSR Launches Online Courseware for the Pragmatic Application of Scientifically Validated AI to Literature Reviews [Morningstar]

MindMed ISPOR 2024: Health Care Resource Use Associated With Generalized Anxiety Disorder Among Adults In The United States [Public Now]

BioLineRx Announces Poster Presentation on Economic Model Data for APHEXDA® (motixafortide) as part of CD34+ Hematopoietic Stem Cell Mobilization in Patients with Multiple Myeloma at ISPOR 2024 [Cison]

Evidation Shares Real-World Data on GLP-1 Use and Social Determinants of Health at ISPOR 2024 [Business Wire]

Komodo Health & Partners Present 33 Real-World Evidence Research Studies at ISPOR 2024 [Business Wire]

Mitsubishi Tanabe Pharma America to Present RADICAVA ORS® Real-World Data at ISPOR 2024 [The Malaysian Reserve]

Milestone® Pharmaceuticals Announces Data Presentations on Etripamil at Heart Rhythm 2024, 2024 Stanford BioDesign Arrhythmia Technologies Retreat, and ISPOR 2024 [EP Lab Digest]

HEORStrategies’ Dr. Naomi Sacks is at ISPOR! [HEOR Strategies]

Cognito Therapeutics Announces Presentation at the ISPOR 2024 [BioSpace]

RWE, HEOR, and Evidence Synthesis Practice at Axtria to Present at ISPOR 2024 Conference [Axtria]


HEOR News Desk

ISPOR News Webpage

Thank You to ISPOR 2024 Media Partners:

A special thank you to ISPOR 2024's Media PartnersThe Evidence Base, AJMC, and the Journal of Medical Economics—and to all the media outlets who are reporting on the conference.



The reporting on ISPOR 2024 from external news sources reflects the views of the authors/media outlets and is not endorsed by ISPOR.